Scientists headed by a team at the Icahn School of Medicine at Mount Sinai have developed an antibody-based platform, which they’ve called adaptive multi-epitope targeting with enhanced avidity (AMETA ...

In a recent study posted to the bioRxiv* pre-print server, researchers identified mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoproteins (NP) epitope flanking regions ...

The novel Epitope Binning-seq technology streamlines antibody epitope mapping and enables the simultaneous evaluation of large numbers of genetically encoded antibodies, grouping them into distinct ...

Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade ...

The concept of viral escape from antibody neutralization seems intimately familiar in our post-COVID world—it’s the reason that we wait in line for new iterations of vaccines while dreadingthe ...

A massive crowd of people shouts as one, “WE ARE ALL INDIVIDUALS!” Then, a lone person in the crowd sheepishly mutters, “I’m not.” The scene above, one of the best from the Monty Python troupe, brings ...

One approach to an HIV vaccine is to teach the immune system to recognize certain protein structures on the viral surface and produce antibodies that bind to those structures and neutralize HIV. A ...

A future vaccine providing protection against a wide range of coronaviruses that jump from their original animal hosts to humans - including SARS-CoV-2, the cause of COVID-19 - may be possible, say ...